|
Existing agents, novel agents, or transplantation for high-risk MDS |
Dec 2020 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes |
Apr 2021 |
Hematology/oncology clinics of North America |
Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
|
Targeting TP53 Mutations in Myelodysplastic Syndromes |
Apr 2020 |
Hematology/oncology clinics of North America |
Myelodysplastic Syndromes (MDS) |
|
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes |
Dec 2020 |
Hematology/oncology and stem cell therapy |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
|
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia |
Dec 2023 |
Immunotherapy |
Aplastic Anemia |
|
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases |
Apr 2023 |
Internal and Emergency Medicine |
Myelodysplastic Syndromes (MDS) |
|
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity |
Jun 2020 |
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity |
Aug 2020 |
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Allogeneic bone marrow transplantation for aplastic anemia |
Dec 2022 |
International Journal of Hematology |
Aplastic Anemia |
|
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia |
Oct 2023 |
International Journal of Hematology |
Aplastic Anemia |
